Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The endothelial function in cardiac surgery.

M Ranucci1

  • 1Cardiothoracic Anesthesia and Intensive Care Department, Policlinico S.Donato, Milan, Italy. cardioanestesia@virgilio.it

Minerva Anestesiologica
|May 10, 2006
PubMed
Summary

Cardiac surgery using cardiopulmonary bypass depletes the body's natural anticoagulants, increasing risks. Low antithrombin levels post-surgery correlate with adverse outcomes, suggesting potential benefits from exogenous antithrombin administration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurocognitive function in procedures correcting severe aortic valve stenosis: patterns and determinants.

Frontiers in cardiovascular medicine·2024
Same author

Sensitivity of serology assay in Covid-19 diagnosis: does the antigen matter?

Journal of biological regulators and homeostatic agents·2021
Same author

A European consensus statement on the use of four-factor prothrombin complex concentrate for cardiac and non-cardiac surgical patients.

Anaesthesia·2020
Same author

The role of fibrinogen and fibrinogen concentrate in cardiac surgery: an international consensus statement from the Haemostasis and Transfusion Scientific Subcommittee of the European Association of Cardiothoracic Anaesthesiology.

Anaesthesia·2019
Same author

Body mass index stratification in hospitalized Italian adults with congenital heart disease in relation to complexity, diagnosis, sex and age.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
Same author

Is there a role for von Willebrand factor/factor VIII concentrate supplementation in complex congenital heart surgery?

Journal of thrombosis and haemostasis : JTH·2018

Area of Science:

  • Cardiovascular Surgery
  • Hemostasis and Thrombosis
  • Endothelial Cell Biology

Background:

  • Cardiopulmonary bypass during cardiac surgery activates coagulation and impairs endothelial cell function.
  • Heparin administration in high doses further challenges the endothelium's natural anticoagulant mechanisms.
  • Key anticoagulant systems, including antithrombin (AT), tissue factor pathway inhibitor, and protein C/S, become depleted post-surgery.

Purpose of the Study:

  • To investigate the consequences of cardiopulmonary bypass on endothelial anticoagulant properties.
  • To highlight the clinical significance of depleted anticoagulant factors, particularly antithrombin, after cardiac surgery.
  • To explore the potential benefits of exogenous antithrombin administration as a preventive strategy.

Main Methods:

Related Experiment Videos

  • Review of the literature on endothelial cell function during cardiopulmonary bypass.
  • Analysis of the coagulation and anticoagulant pathways affected by cardiac surgery.
  • Examination of evidence linking antithrombin levels to clinical outcomes.

Main Results:

  • Cardiac surgery with cardiopulmonary bypass leads to significant thrombin generation and depletion of natural anticoagulants.
  • Antithrombin activity below 50% post-surgery is associated with increased rates of surgical revision, thromboembolism, and neurological events.
  • Exogenous antithrombin is known to limit thrombin formation, but its clinical impact requires further evidence-based investigation.

Conclusions:

  • Endothelial dysfunction and anticoagulant depletion are critical issues following cardiopulmonary bypass.
  • Maintaining adequate antithrombin levels appears crucial for improving outcomes in cardiac surgery patients.
  • Further research is needed to establish evidence-based guidelines for exogenous antithrombin administration to mitigate risks.